View of Treatment-arm count, Phase 2 information value, and complexity as predictors of Phase 3 success in neurological drug development

Return to Article Details Treatment-arm count, Phase 2 information value, and complexity as predictors of Phase 3 success in neurological drug development Download Download PDF